img

Global Tumor Treatment Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tumor Treatment Drug Market Research Report 2024

Tumor is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
According to Mr Accuracy reports new survey, global Tumor Treatment Drug market is projected to reach US$ 2473.9 million in 2029, increasing from US$ 1623 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor Treatment Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tumor Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others

Segment by Application


Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor Treatment Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tumor Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Treatment Drug Market Perspective (2018-2029)
2.2 Tumor Treatment Drug Growth Trends by Region
2.2.1 Global Tumor Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor Treatment Drug Historic Market Size by Region (2018-2024)
2.2.3 Tumor Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Tumor Treatment Drug Market Dynamics
2.3.1 Tumor Treatment Drug Industry Trends
2.3.2 Tumor Treatment Drug Market Drivers
2.3.3 Tumor Treatment Drug Market Challenges
2.3.4 Tumor Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Treatment Drug Players by Revenue
3.1.1 Global Top Tumor Treatment Drug Players by Revenue (2018-2024)
3.1.2 Global Tumor Treatment Drug Revenue Market Share by Players (2018-2024)
3.2 Global Tumor Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Treatment Drug Revenue
3.4 Global Tumor Treatment Drug Market Concentration Ratio
3.4.1 Global Tumor Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Treatment Drug Revenue in 2022
3.5 Tumor Treatment Drug Key Players Head office and Area Served
3.6 Key Players Tumor Treatment Drug Product Solution and Service
3.7 Date of Enter into Tumor Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Treatment Drug Breakdown Data by Type
4.1 Global Tumor Treatment Drug Historic Market Size by Type (2018-2024)
4.2 Global Tumor Treatment Drug Forecasted Market Size by Type (2024-2029)
5 Tumor Treatment Drug Breakdown Data by Application
5.1 Global Tumor Treatment Drug Historic Market Size by Application (2018-2024)
5.2 Global Tumor Treatment Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor Treatment Drug Market Size (2018-2029)
6.2 North America Tumor Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tumor Treatment Drug Market Size by Country (2018-2024)
6.4 North America Tumor Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Treatment Drug Market Size (2018-2029)
7.2 Europe Tumor Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tumor Treatment Drug Market Size by Country (2018-2024)
7.4 Europe Tumor Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Tumor Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tumor Treatment Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Tumor Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Treatment Drug Market Size (2018-2029)
9.2 Latin America Tumor Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tumor Treatment Drug Market Size by Country (2018-2024)
9.4 Latin America Tumor Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Tumor Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tumor Treatment Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Tumor Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Tumor Treatment Drug Introduction
11.1.4 Roche Revenue in Tumor Treatment Drug Business (2018-2024)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Tumor Treatment Drug Introduction
11.2.4 Celgene Revenue in Tumor Treatment Drug Business (2018-2024)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Tumor Treatment Drug Introduction
11.3.4 Novartis Revenue in Tumor Treatment Drug Business (2018-2024)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Tumor Treatment Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2018-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Tumor Treatment Drug Introduction
11.5.4 Johnson & Johnson Revenue in Tumor Treatment Drug Business (2018-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Detail
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Tumor Treatment Drug Introduction
11.6.4 Merck & Co. Revenue in Tumor Treatment Drug Business (2018-2024)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Tumor Treatment Drug Introduction
11.7.4 AstraZeneca Revenue in Tumor Treatment Drug Business (2018-2024)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Tumor Treatment Drug Introduction
11.8.4 Pfizer Revenue in Tumor Treatment Drug Business (2018-2024)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Tumor Treatment Drug Introduction
11.9.4 Amgen Revenue in Tumor Treatment Drug Business (2018-2024)
11.9.5 Amgen Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Detail
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Tumor Treatment Drug Introduction
11.10.4 Eli Lilly Revenue in Tumor Treatment Drug Business (2018-2024)
11.10.5 Eli Lilly Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Detail
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Tumor Treatment Drug Introduction
11.11.4 AbbVie Revenue in Tumor Treatment Drug Business (2018-2024)
11.11.5 AbbVie Recent Development
11.12 Takeda
11.12.1 Takeda Company Detail
11.12.2 Takeda Business Overview
11.12.3 Takeda Tumor Treatment Drug Introduction
11.12.4 Takeda Revenue in Tumor Treatment Drug Business (2018-2024)
11.12.5 Takeda Recent Development
11.13 Astellas
11.13.1 Astellas Company Detail
11.13.2 Astellas Business Overview
11.13.3 Astellas Tumor Treatment Drug Introduction
11.13.4 Astellas Revenue in Tumor Treatment Drug Business (2018-2024)
11.13.5 Astellas Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Detail
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Tumor Treatment Drug Introduction
11.14.4 Ipsen Revenue in Tumor Treatment Drug Business (2018-2024)
11.14.5 Ipsen Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Detail
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Tumor Treatment Drug Introduction
11.15.4 Sanofi Revenue in Tumor Treatment Drug Business (2018-2024)
11.15.5 Sanofi Recent Development
11.16 Bayer
11.16.1 Bayer Company Detail
11.16.2 Bayer Business Overview
11.16.3 Bayer Tumor Treatment Drug Introduction
11.16.4 Bayer Revenue in Tumor Treatment Drug Business (2018-2024)
11.16.5 Bayer Recent Development
11.17 Biogen Idec
11.17.1 Biogen Idec Company Detail
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Tumor Treatment Drug Introduction
11.17.4 Biogen Idec Revenue in Tumor Treatment Drug Business (2018-2024)
11.17.5 Biogen Idec Recent Development
11.18 Teva
11.18.1 Teva Company Detail
11.18.2 Teva Business Overview
11.18.3 Teva Tumor Treatment Drug Introduction
11.18.4 Teva Revenue in Tumor Treatment Drug Business (2018-2024)
11.18.5 Teva Recent Development
11.19 Otsuka
11.19.1 Otsuka Company Detail
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Tumor Treatment Drug Introduction
11.19.4 Otsuka Revenue in Tumor Treatment Drug Business (2018-2024)
11.19.5 Otsuka Recent Development
11.20 Eisai
11.20.1 Eisai Company Detail
11.20.2 Eisai Business Overview
11.20.3 Eisai Tumor Treatment Drug Introduction
11.20.4 Eisai Revenue in Tumor Treatment Drug Business (2018-2024)
11.20.5 Eisai Recent Development
11.21 Merck KGaA
11.21.1 Merck KGaA Company Detail
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Tumor Treatment Drug Introduction
11.21.4 Merck KGaA Revenue in Tumor Treatment Drug Business (2018-2024)
11.21.5 Merck KGaA Recent Development
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Detail
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Tumor Treatment Drug Introduction
11.22.4 Gilead Sciences Revenue in Tumor Treatment Drug Business (2018-2024)
11.22.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tumor Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy (Biologic Therapy)
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Others
Table 7. Global Tumor Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Tumor Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Tumor Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Tumor Treatment Drug Market Share by Region (2018-2024)
Table 11. Global Tumor Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Tumor Treatment Drug Market Share by Region (2024-2029)
Table 13. Tumor Treatment Drug Market Trends
Table 14. Tumor Treatment Drug Market Drivers
Table 15. Tumor Treatment Drug Market Challenges
Table 16. Tumor Treatment Drug Market Restraints
Table 17. Global Tumor Treatment Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Tumor Treatment Drug Market Share by Players (2018-2024)
Table 19. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2022)
Table 20. Ranking of Global Top Tumor Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Tumor Treatment Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tumor Treatment Drug Product Solution and Service
Table 24. Date of Enter into Tumor Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tumor Treatment Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Tumor Treatment Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Tumor Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Tumor Treatment Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Tumor Treatment Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Tumor Treatment Drug Revenue Market Share by Application (2018-2024)
Table 32. Global Tumor Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Tumor Treatment Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Tumor Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Tumor Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Tumor Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Tumor Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Tumor Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Tumor Treatment Drug Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Tumor Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Tumor Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Tumor Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Tumor Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Tumor Treatment Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Tumor Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Tumor Treatment Drug Product
Table 52. Roche Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Celgene Company Detail
Table 55. Celgene Business Overview
Table 56. Celgene Tumor Treatment Drug Product
Table 57. Celgene Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Tumor Treatment Drug Product
Table 62. Novartis Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Tumor Treatment Drug Product
Table 67. Bristol-Myers Squibb Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Tumor Treatment Drug Product
Table 72. Johnson & Johnson Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Merck & Co. Company Detail
Table 75. Merck & Co. Business Overview
Table 76. Merck & Co. Tumor Treatment Drug Product
Table 77. Merck & Co. Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 78. Merck & Co. Recent Development
Table 79. AstraZeneca Company Detail
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Tumor Treatment Drug Product
Table 82. AstraZeneca Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Pfizer Company Detail
Table 85. Pfizer Business Overview
Table 86. Pfizer Tumor Treatment Drug Product
Table 87. Pfizer Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Amgen Company Detail
Table 90. Amgen Business Overview
Table 91. Amgen Tumor Treatment Drug Product
Table 92. Amgen Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Eli Lilly Company Detail
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Tumor Treatment Drug Product
Table 97. Eli Lilly Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. AbbVie Company Detail
Table 100. AbbVie Business Overview
Table 101. AbbVie Tumor Treatment Drug Product
Table 102. AbbVie Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 103. AbbVie Recent Development
Table 104. Takeda Company Detail
Table 105. Takeda Business Overview
Table 106. Takeda Tumor Treatment Drug Product
Table 107. Takeda Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 108. Takeda Recent Development
Table 109. Astellas Company Detail
Table 110. Astellas Business Overview
Table 111. Astellas Tumor Treatment Drug Product
Table 112. Astellas Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 113. Astellas Recent Development
Table 114. Ipsen Company Detail
Table 115. Ipsen Business Overview
Table 116. Ipsen Tumor Treatment Drug Product
Table 117. Ipsen Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 118. Ipsen Recent Development
Table 119. Sanofi Company Detail
Table 120. Sanofi Business Overview
Table 121. Sanofi Tumor Treatment Drug Product
Table 122. Sanofi Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 123. Sanofi Recent Development
Table 124. Bayer Company Detail
Table 125. Bayer Business Overview
Table 126. Bayer Tumor Treatment Drug Product
Table 127. Bayer Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 128. Bayer Recent Development
Table 129. Biogen Idec Company Detail
Table 130. Biogen Idec Business Overview
Table 131. Biogen Idec Tumor Treatment Drug Product
Table 132. Biogen Idec Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 133. Biogen Idec Recent Development
Table 134. Teva Company Detail
Table 135. Teva Business Overview
Table 136. Teva Tumor Treatment Drug Product
Table 137. Teva Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 138. Teva Recent Development
Table 139. Otsuka Company Detail
Table 140. Otsuka Business Overview
Table 141. Otsuka Tumor Treatment Drug Product
Table 142. Otsuka Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 143. Otsuka Recent Development
Table 144. Eisai Company Detail
Table 145. Eisai Business Overview
Table 146. Eisai Tumor Treatment Drug Product
Table 147. Eisai Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 148. Eisai Recent Development
Table 149. Merck KGaA Company Detail
Table 150. Merck KGaA Business Overview
Table 151. Merck KGaA Tumor Treatment Drug Product
Table 152. Merck KGaA Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 153. Merck KGaA Recent Development
Table 154. Gilead Sciences Company Detail
Table 155. Gilead Sciences Business Overview
Table 156. Gilead Sciences Tumor Treatment Drug Product
Table 157. Gilead Sciences Revenue in Tumor Treatment Drug Business (2018-2024) & (US$ Million)
Table 158. Gilead Sciences Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Treatment Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Tumor Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy (Biologic Therapy) Features
Figure 6. Hormonal Therapy Features
Figure 7. Others Features
Figure 8. Global Tumor Treatment Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 9. Global Tumor Treatment Drug Market Share by Application: 2022 VS 2029
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Respiratory/Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Tumor Treatment Drug Report Years Considered
Figure 17. Global Tumor Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Tumor Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Tumor Treatment Drug Market Share by Region: 2022 VS 2029
Figure 20. Global Tumor Treatment Drug Market Share by Players in 2022
Figure 21. Global Top Tumor Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Treatment Drug as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Tumor Treatment Drug Revenue in 2022
Figure 23. North America Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Tumor Treatment Drug Market Share by Country (2018-2029)
Figure 25. United States Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Tumor Treatment Drug Market Share by Country (2018-2029)
Figure 29. Germany Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Tumor Treatment Drug Market Share by Region (2018-2029)
Figure 37. China Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Tumor Treatment Drug Market Share by Country (2018-2029)
Figure 45. Mexico Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Tumor Treatment Drug Market Share by Country (2018-2029)
Figure 49. Turkey Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Tumor Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 52. Celgene Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 53. Novartis Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 56. Merck & Co. Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 58. Pfizer Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 59. Amgen Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 60. Eli Lilly Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 61. AbbVie Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 62. Takeda Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 63. Astellas Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 64. Ipsen Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 65. Sanofi Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 66. Bayer Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 67. Biogen Idec Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 68. Teva Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 69. Otsuka Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 70. Eisai Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 71. Merck KGaA Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 72. Gilead Sciences Revenue Growth Rate in Tumor Treatment Drug Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries